# Tigecycline

NDC: 63323-960
Generic name: Tigecycline
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20161201

FDA application: NDA205645

## Active ingredients

- TIGECYCLINE: 50 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-960"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-960
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acf5dbe5-ca75-4300-816f-b3f4625f6e7d